Cancer diagnosis can be devastating, but for some it gives permission to live more radically

by Kevin Dew, Alex Broom, Chris Cunningham, Elizabeth Dennett, Kerry Chamberlain and Richard Egan,The ConversationCredit: Ivan Samkov from PexelsA diagnosis of life-limiting cancer can be overwh

Updated on: August 28,2024

Cancer diagnosis can be devastating, but for some it gives permission to live more radically

by Kevin Dew, Alex Broom, Chris Cunningham, Elizabeth Dennett, Kerry Chamberlain and Richard Egan,The ConversationCredit: Ivan Samkov from PexelsA diagnosis of life-limiting cancer can be overwh

Updated on:August 28,2024

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di

Updated on: August 28,2024

Adding metastasis-directed radiation therapy boosts progression-free survival in metastatic pancreatic cancer

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding metastasis-di

Updated on:August 28,2024

Advancing towards a novel, highly accurate method for cervical cancer screening

byFujita Health UniversityAfter a preliminary screening round, researchers identified a set of microRNAs (miRNAs) and cytokines that are abnormally expressed in serum and mucus samples in cases

Updated on: August 28,2024

Advancing towards a novel, highly accurate method for cervical cancer screening

byFujita Health UniversityAfter a preliminary screening round, researchers identified a set of microRNAs (miRNAs) and cytokines that are abnormally expressed in serum and mucus samples in cases

Updated on:August 28,2024

Drug bypasses suppressive immune cells to unleash immunotherapy

by Marta Wegorzewska,Washington University School of MedicineImmunobiologists Robert Schreiber, Ph.D., (left) and Hussein Sultan, Ph.D., of Washington University School of Medicine in St. Louis,

Updated on: August 28,2024

Drug bypasses suppressive immune cells to unleash immunotherapy

by Marta Wegorzewska,Washington University School of MedicineImmunobiologists Robert Schreiber, Ph.D., (left) and Hussein Sultan, Ph.D., of Washington University School of Medicine in St. Louis,

Updated on:August 28,2024

AI tool 'DeepHRD' accelerates cancer treatment decisions

byUniversity of California - San DiegoFirst author Erik Bergstrom showcasing a biopsy analysis completed with DeepHRD, a new artificial intelligence tool that can detect clinically actionable ge

Updated on: August 28,2024

AI tool 'DeepHRD' accelerates cancer treatment decisions

byUniversity of California - San DiegoFirst author Erik Bergstrom showcasing a biopsy analysis completed with DeepHRD, a new artificial intelligence tool that can detect clinically actionable ge

Updated on:August 28,2024

New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

byUniversity of SheffieldADT stimulates the PV accumulation of FR-β+ TAMs in mouse (Myc-CaP) and localized, human prostate tumors. Credit:Journal for ImmunoTherapy of Cancer(2024). D

Updated on: August 28,2024

New hope for prostate cancer: New form of immunotherapy could prevent resistance to hormone therapy

byUniversity of SheffieldADT stimulates the PV accumulation of FR-β+ TAMs in mouse (Myc-CaP) and localized, human prostate tumors. Credit:Journal for ImmunoTherapy of Cancer(2024). D

Updated on:August 28,2024

Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

byKeck School of Medicine of USCGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In an innovative study of glioblastoma, scientists used artificial intelligence (AI) to reprogram ca

Updated on: August 28,2024

Using AI, researchers pioneer a potential new immunotherapy approach for treating glioblastoma

byKeck School of Medicine of USCGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0In an innovative study of glioblastoma, scientists used artificial intelligence (AI) to reprogram ca

Updated on:August 28,2024

Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

bySt. Jude Children's Research Hospital(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of C

Updated on: August 28,2024

Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

bySt. Jude Children's Research Hospital(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of C

Updated on:August 28,2024

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Updated on: August 28,2024

Age impacts pharmacogenomics and treatment outcomes for most common form of leukemia

bySt. Jude Children's Research HospitalJun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura

Updated on:August 28,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on: August 28,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on:August 28,2024

Novel approach to study hypoxia enables identification of a marker for ovarian cancers

by Myreille Larouche,University of MontrealLong-term severe hypoxia adaptation induces EMT-like morphological changes. Credit:Cancer Gene Therapy(2024). DOI: 10.1038/s41417-024-00795

Updated on: August 28,2024

Novel approach to study hypoxia enables identification of a marker for ovarian cancers

by Myreille Larouche,University of MontrealLong-term severe hypoxia adaptation induces EMT-like morphological changes. Credit:Cancer Gene Therapy(2024). DOI: 10.1038/s41417-024-00795

Updated on:August 28,2024

Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics

byBrigham and Women’s HospitalGlobal characterization of the melanoma samples and their expression of CEACAM1. Credit:Communications Medicine(2024). DOI: 10.1038/s43856-024-00525-8Yu

Updated on: August 28,2024

Q&A: Researchers discuss identifying potential new protein targets for melanoma therapeutics

byBrigham and Women’s HospitalGlobal characterization of the melanoma samples and their expression of CEACAM1. Credit:Communications Medicine(2024). DOI: 10.1038/s43856-024-00525-8Yu

Updated on:August 28,2024